TH EURO 4 EURO · • Congress Material • Coffee breaks & Lunch • Certifi cate of attendance...
2
Berlin 16. /17. November 2012 Grand Hyatt Berlin Scientific Committee: K.-H. Kuck, Germany P. Della Bella, Italy G. Hindricks, Germany P. Jais, France Meeting: 4 th Euro VT/VF Meeting 2012 Date: 16./17. November 2012 Scientific Committee: K.-H. Kuck, Hamburg (DE), P. Della Bella, Milan (IT) G. Hindricks, Leipzig (DE), P. Jais, Bordeaux (FR) Venue: Grand Hyatt Berlin Marlene-Dietrich-Platz 2, D-10785 Berlin Tel.: +49 (0) 30 25 53 12 34, Fax: +49 (0) 30 25 53 12 35 E-Mail: [email protected], www.berlin.grand.hyatt.com Language: The official conference language is English. Registration fee: By 15. Oct., 2012: € 485,–, From 16. Oct., 2012: € 600,– Registration fee includes: • Admission to the Scientific sessions • Congress Material • Coffee breaks & Lunch • Certificate of attendance Online registration: www.euro-vtvf.eu Organizer: Prof. Dr. Karl-Heinz Kuck Euro EP uG c/o Asklepios Klinik St. Georg Lohmühlenstraße 5, D-20099 Hamburg Tel.: +49 (0) 40 18 18-85 23 08, Fax: +49 (0) 40 18 18-85 44 44 E-Mail: [email protected], www.asklepios.com Congress Agency: wikonect GmbH Hagenauer Straße 53, D-65203 Wiesbaden Tel.: +49 (0) 611 20 48 09-0, Fax: +49 (0) 611 20 48 09-10 E-Mail: [email protected], www.wikonect.de 2012 4 TH EURO WWW.EURO-VTVF.EU GENERAL INFORMATION Partner: The meeting is accredited by: The European Board of Accreditation in Cardiology WWW.EURO-VTVF.EU 2012 4 TH EURO Dear colleagues, Dear friends, Encouraged by the great success of the last three meetings, we will be convening the 4 th Euro VT/VF Meeting on 16. / 17. November 2012 in Berlin. We would like to cordially invite you to attend our meeting. The first treatment of ventricular tachycardia by open heart surgery in the early 1980‘s and by percutaneous catheter procedures, using first DC Shock and later radiofrequency, current in the mid 1980‘s is almost more than 30 years ago. The experience was limited to patients with life-threatening ventricular tachycardia refractory to medical treatment. These procedures were performed in a few centers around the world by only very experienced physicians. The introduction of the implantable defibrillator by Michel Mirowski substantially changed the treatment of VT/VF and made catheter ablation a procedure, which in many countries was mostly performed in patients following multiple ICD interventions. In most patients without structural heart disease new mechanistic insights based on catheter ablation procedures made catheter ablation a first line treatment. Following the enthusiasm in catheter ablation of atrial fibrillation new interests of physicians and industry has initiated an upcoming revival of ventricular tachycardia / fibrillation treatment beyond the ICD. This has led to new studies in the field of ICD and CRT but also of catheter ablation including preventive ablation procedures in ICD patients. Further interest has also been stimulated by the use of diagnostic tools such as MRI, allowing better understanding of the underlying substrate. The 4th EURO VT/VF symposium in Berlin, Germany, will address the entire field of VT/VF from genetics, mechanisms, diagnostics to therapeutics by bringing international physicians together. We hope that this meeting will find your interest and we look forward to seeing you in Berlin. K.-H. Kuck P. Della Bella G. Hindricks P. Jais PREFACE
Transcript of TH EURO 4 EURO · • Congress Material • Coffee breaks & Lunch • Certifi cate of attendance...
Berlin16. /17. November 2012
Grand Hyatt Berlin
Scientifi c Committee:
K.-H. Kuck, GermanyP. Della Bella, ItalyG. Hindricks, GermanyP. Jais, France
Meeting: 4th Euro VT/VF Meeting 2012
Date: 16./17. November 2012
Scientifi c Committee: K.-H. Kuck, Hamburg (DE), P. Della Bella, Milan (IT)G. Hindricks, Leipzig (DE), P. Jais, Bordeaux (FR)
Venue: Grand Hyatt BerlinMarlene-Dietrich-Platz 2, D-10785 BerlinTel.: +49 (0) 30 25 53 12 34, Fax: +49 (0) 30 25 53 12 35E-Mail: [email protected], www.berlin.grand.hyatt.com
Language: The offi cial conference language is English.
Registration fee:By 15. Oct., 2012: € 485,–, From 16. Oct., 2012: € 600,–
Registration fee includes:• Admission to the Scientifi c sessions• Congress Material• Coffee breaks & Lunch• Certifi cate of attendance
Online registration: www.euro-vtvf.eu
Organizer: Prof. Dr. Karl-Heinz KuckEuro EP uGc/o Asklepios Klinik St. GeorgLohmühlenstraße 5, D-20099 Hamburg Tel.: +49 (0) 40 18 18-85 23 08, Fax: +49 (0) 40 18 18-85 44 44E-Mail: [email protected], www.asklepios.com
Congress Agency:
wikonect GmbHHagenauer Straße 53, D-65203 WiesbadenTel.: +49 (0) 611 20 48 09-0, Fax: +49 (0) 611 20 48 09-10 E-Mail: [email protected], www.wikonect.de
2012
4TH EURO
WWW.EURO-VTVF.EU
GENERAL INFORMATION
Partner:
The meeting is accredited by: The European Board of Accreditation in Cardiology
WWW.EURO-VTVF.EU
2012
4TH EURO
Dear colleagues,Dear friends,
Encouraged by the great success of the last three meetings, we will be convening the 4th Euro VT/VF Meeting on 16. / 17. November 2012 in Berlin. We would like to cordially invite you to attend our meeting.
The fi rst treatment of ventricular tachycardia by open heart surgery in the early 1980‘s and by percutaneous catheter procedures, using fi rst DC Shock and later radiofrequency, current in the mid 1980‘s is almost more than 30 years ago. The experience was limited to patients with life-threatening ventricular tachycardia refractory to medical treatment. These procedures were performed in a few centers around the world by only very experienced physicians.
The introduction of the implantable defi brillator by Michel Mirowski substantially changed the treatment of VT/VF and made catheter ablation a procedure, which in many countries was mostly performed in patients following multiple ICD interventions. In most patients without structural heart disease new mechanistic insights based on catheter ablation procedures made catheter ablation a fi rst line treatment.
Following the enthusiasm in catheter ablation of atrial fi brillation new interests of physicians and industry has initiated an upcoming revival of ventricular tachycardia / fi brillation treatment beyond the ICD. This has led to new studies in the fi eld of ICD and CRT but also of catheter ablation including preventive ablation procedures in ICD patients. Further interest has also been stimulated by the use of diagnostic tools such as MRI, allowing better understanding of the underlying substrate.
The 4th EURO VT/VF symposium in Berlin, Germany, will address the entire fi eld of VT/VF from genetics, mechanisms, diagnostics to therapeutics by bringing international physicians together.
We hope that this meeting will fi nd your interest and we look forward to seeing you in Berlin.
K.-H. KuckP. Della BellaG. HindricksP. Jais
PREFACE
9:00 WelcomeK.-H. Kuck, Germany
I. Session: Controversial issues in CRTChairs: C. Linde, Schweden; J. Bax, Netherlands
09:15 Role of echo in assessment of dyssynchrony. Does it add something to the ECG?O. Breithardt, Germany
09:35 Role of ECG and imaging to detect the non-responderJ. Bax, Netherlands
09:55 Electrocardiographic imaging of substrate and CRT in heart failure patientsY. Rudy, USA
10:15 – 10:35 Coffee Break
II. Session: ICD-Therapy: diffi cult issuesChairs: R. Cappato, Italy; W.S. Tzou, USA
10:35 Co-morbidities and ICD-therapy: too healthy or too sick to profi t?R. Goldberger, USA
10:55 No ICD therapy until EOL: replace or remove?D. Bänsch, Germany
11:15 Driving and sports for ICD patients: are the restric-tions evidence-based?A. Ng, United Kingdom
11:35 Age limits for ICD implantation and ICD deactiva-tion at the end of life?W.S. Tzou, USA
11:55 The subcutaneous ICD – for all primary prevention patients?R. Cappato, Italy
12:15 – 13:15 Lunch
III. Session: Lead extractionsChairs: M. Bongiorni, Italy; C. Israel, Germany
13:15 Vegetation’s – how large is too large?C. Israel, Germany
13:35 Does the laser still reign supreme?P. Mazzone, Italy
13:55 How many tools are needed for safe and effective lead extraction?M. Bongiorni, Italy
14:15 How much training is needed to become an extractionist?I. Fernandez Lozano, Spain
14:35 – 14:55 Coffee Break
IV. Session: Genotyping for screening and risk Stratifi cation? Chairs: S.Kääb, Germany; W. Mc Kenna, United Kingdom
14:55 Genotyping in arrhythmia patientsS. Kääb, Germany
15:15 Risk stratifi cation after MIT. Tönnis, Germany
15:35 Risk stratifi cation in ARVD D. Corrado, Italy
15:55 Risk stratifi cation in HCM W. Mc Kenna, United Kingdom
V. Session: Role of cardiac imaging for risk strati-fi cation and catheter ablation Chairs: H.R. Halperin, USA; W. Stevenson, USA
16:15 MR imaging to assess fi brosis in the atrium and ventricleN.F. Marrouche, USA
16:35 Cardiac CT imaging to detect fi brosisT. Dickfeld, USA
16:55 Cardiac imaging to plan catheter ablationK. Zeppenfeld, Netherlands
17:15 Special lecture: MRI interventional suites for catheter ablation: far away?G. Hindricks, Germany
17:35 Summary day 1K.-H. Kuck, Germany
2012
4TH EUROFRIDAY
16. NOVEMBER 2012
09:00 Welcome and program introduction day 2P. Della Bella, Italy
09:05 State of the art lecture: Indications for catheter ablation of VT/VF – guidelines and gapsW. Stevenson, USA
VI. Session: Catheter ablation in specifi c patient entities: indications techniques and outcomeChairs: D. Wilber, USA; H. Kottkamp, Switzerland
09:30 Idiopathic outfl ow tract VPBs and VTF. Bogun, USA
09:45 Tricuspid, mitral annuli and papillary muscleD. Wilber, USA
10:00 Fascicular ventricular tachycardiaF. Ouyang, Germany
10:15 Catheter ablation in channelopathies: anything new?W. Nademanee, USA
10:30 Chagas disease: what Europe should know!J. Atié, Brasil
VII. Session: Post-infarct VT catheter ablation Chairs: S. Willems, Germany; A. Ng, United Kingdom
10:45 The 12 lead ECG – site of originH. Kottkamp, Switzerland
11:00 – 11:15 Coffee Break
11:15 Ultra high density mappingH. Nakagawa, USA
11:30 Sinus maps to guide catheter ablationP. Dellla Bella, Italy
11:45 Encircling of the scarR. Tilz, Germany
17. NOVEMBER 2012SATURDAY
VIII. Session: New techniques for VT ablationChairs: F. Sacher, France; C. Piorkowski, Germany
12:00 Contact sensing technologiesP. Della Bella, Italy
12:15 New mapping technologiesC. Piorkowski, Germany
12:30 Novel technologies for better lesion creationF.H. Wittkampf, Netherlands
12:45 – 13:30 Lunch
IX. Session: Epicadial VT-ablationChairs: W. Stevenson, USA; P. Della Bella, Italy
13:30 How to obtain epicardial access?A. D’Avila, USA
13:45 When and how to ablate epicardially?F. Marchlinski, USA*
14:00 How to prevent and manage complications?F. Sacher, France
14:15 How to decide on the initial approach: endo, epi or both?K. Shivkumar, USA
X Session: Randomized VT-ablation studies – recent and upcomingChairs: V. Reddy, USA; F. Ouyang, Germany
14:30 The US-VT Trial V. Reddy, USA
14:40 The Partita Trial P. Della Bella, Italy
14:50 The Berlin StudyK.-H. Kuck, Germany
XI Debate: Circulatory support for unstable VTsChairs: K.-H. Kuck, Germany; G. Hindricks, Germany
15:00 Pro: V. Reddy, USA
15:20 Contra: G. Maccabelli, Italy
15:40 Summary day 2G. Hindricks, Germany
